Zainab Shinkafi-Bagudu: A Champion for Global Cancer Control – MEDICAID CANCER FOUNDATION

MEDICAID CANCER FOUNDATION shared a post on LinkedIn:

“Zainab Shinkafi-Bagudu: A Champion for Global Cancer Control – Vote for UICC President-Elect!

Let’s make a difference together. Join us in supporting our CEO Dr. Zainab Shinkafi-Bagudu for UICC President-Elect!

Dr. Shinkafi-Bagudu is a highly respected leader in the global fight against cancer. With over 30 years of experience in healthcare, she brings a wealth of knowledge and dedication to the table.

Here’s why Dr. Shinkafi-Bagudu is the right candidate for UICC President-Elect:
– Proven Track Record:
– 20 years in child health and a successful tenure as CEO of a diagnostic center.
– Founder and Chair of Medicaid Cancer Foundation, actively advocating for cancer patients globally.
– 3 terms on the UICC board, actively contributing to policy and advocacy.
– Current Senior Advisor to the Nigerian Health Minister and Commissioner on influential cancer commissions.

– Vision for a Stronger UICC:
– Increased fundraising to support member organizations in their fight against cancer.
– Building capacity for community health workers, the backbone of healthcare.
– Utilizing digital technology and social media for broader education and awareness.
– Amplifying the voices of patients, particularly in underserved areas.
– Promoting global equity in research, technology, and treatment access.
– Championing the critical issue of childhood cancer.

Dr. Shinkafi-Bagudu shares our commitment to improving the lives of cancer patients worldwide. Her passion, experience, and clear vision make her the ideal candidate to lead UICC in the years to come.

Join the movement!
– Share this message with your network.
– Connect Dr. Shinkafi-Bagudu with other voting members
– Learn more about Dr. Shinkafi-Bagudu & her work:
– Social Media: @drzus on instagram

Together, we can make cancer control a global priority. Let’s elect Dr. Zainab Shinkafi-Bagudu as UICC President-Elect!”

Learn more on OncoDaily.

Source: MEDICAID CANCER FOUNDATION/LinkedIn